Author | Matthew P. Goetz, MD | OncLive

Author | Matthew P. Goetz, MD

Articles

Dr. Goetz on the Use of ctDNA in the MONARCH-3 Trial in HR+/HER2- Breast Cancer

January 09, 2020

Video

Matthew P. Goetz, MD, Mayo Clinic, discusses the use of circulating tumor DNA in the phase III MONARCH-3 trial in hormone receptor–positive, HER2-negative breast cancer.

Dr. Goetz on Adverse Events With Aromatase Inhibitors in Breast Cancer

September 25, 2019

Video

Matthew P. Goetz, MD, discusses adverse events associated with aromatase inhibitors.

Dr. Goetz on Treatment Beyond Progression on CDK4/6 Inhibitors in HR+ Breast Cancer

August 23, 2019

Video

Matthew P. Goetz, MD, consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses treatment beyond progression on CDK4/6 inhibitors in hormone receptor (HR)-positive breast cancer.

Dr. Goetz on Treatment Challenges for ESR1-Mutant Breast Cancer

August 16, 2019

Video

Matthew P. Goetz, MD, consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses the treatment landscape of estrogen receptor (ER)–positive breast cancer and advances made within the last 5 years.

x